
Build Your Quality Management System
Build a lean, scalable QMS to comply with ISO 13485, MDSAP, FDA, and MDR requirements, with personalized guidance from quality experts every step of the way
Transform your vision into a functional low-fidelity prototype and a vendor-ready requirements document. Finish the program by connecting with vetted development firms and testing experts to build your proof of concept.

By the end of this program, you will have a testable prototype and the documentation to take it to production.
A functional low-fidelity prototype you can demo to users and investors
A vendor-ready requirements document with user stories and technical specs
Clinical workflow validation for your core product flows
Introductions to vetted development firms and testing partners
Technical architecture decisions documented for your build phase
A sprint-based program that takes you from product vision to a testable prototype with vendor introductions.
Transform your product vision into a vendor-ready requirements document with user stories, workflow diagrams, and technical constraints mapped out.
Build a functional low-fidelity prototype using no-code or low-code tools that you can put in front of users and investors within weeks.
Connect with vetted development firms and testing experts from Rellia's partner network to take your prototype to the next stage.
Technical Clarity
Define your product's technical architecture and constraints before spending on development — saving months and dollars.
Spec-Ready Output
Leave with documentation that a development team can estimate and build from immediately.
Clinical Workflow Fit
Validate that your product integrates into real clinical workflows, not just theoretical use cases.
Build-Ready
Exit with a prototype, requirements doc, and vendor introductions to begin your build phase with confidence.
8 weeks from concept to prototype with vendor-ready specs
Join the waitlist to be notified when the Low-Fidelity Prototype Lab opens.
Join the waitlist and we'll notify you when the next cohort starts.